Merck’s Oral Antiviral Data In COVID-19 May Change Pandemic Outlook

 
• By Joseph Haas
  
Coronavirus with cardio lines, cellular designs and lungs
Oral antiviral shows ability to reduce risk of COVID-19 hospitalization and death
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip